Contraindications for Fruquintinib

Fruquintinib (Fruquintinib) is an oral small molecule targeted therapy drug, mainly used for the treatment of digestive system tumors such as advanced colorectal cancer and gastric cancer. However, the use of any drug comes with a series of contraindications, i.e. certain situations where the drug is prohibited or used with caution. Please note that specific medical guidance and contraindications may change over time and new research, so the best course of action is to consult a professional physician or consult the most current medical literature.

The following are some possible contraindications to the use of fruquintinib:

1. Drug Hypersensitivity: Fruquintinib should be contraindicated in patients with allergic reactions to fruquintinib or similar drugs. Anaphylaxis may manifest as itchy skin, hives, shortness of breath and other symptoms, and may sometimes cause a more severe allergic reaction that requires immediate medical attention.

2. Serious cardiovascular disease: Fruquintinib may have an impact on the cardiovascular system, so it should be used with extreme caution in patients with severe heart disease, angina, arrhythmia and other cardiovascular diseases. In these cases, doctors may need to evaluate the patient's cardiovascular status and weigh the benefits and risks of treatment.

3. Hypertension: The use of fruquintinib may cause hypertension, so patients with severe hypertension need to be cautious when using fruquintinib. The doctor may monitor the patient's blood pressure and adjust the treatment plan or provide corresponding antihypertensive treatment if necessary.

4. Bleeding risk: Due to the inhibitory effect of fruquintinib on angiogenesis, the risk of bleeding may be increased. Therefore, patients with a bleeding tendency or who are receiving anticoagulant therapy may need to avoid the use of fruquintinib or use it with extreme caution.

5. Preparation before treatment: Before using fruquintinib, the doctor may evaluate the patient's systemic condition, including liver function, kidney function, etc. Patients with severe hepatic or renal impairment may need to reduce the dose of the drug or choose an alternative treatment modality.

6. Pregnancy and lactation: The effects of fruquintinib on the fetus are not fully understood, so use during pregnancy and lactation requires careful consideration. Patients should use effective contraception while receiving fruquintinib and consult their physician for additional advice.

7. Age and overall health: Elderly patients or patients with poor overall health may need to use fruquintinib with more caution, as these patients may be at higher risk from the drug.

It needs to be emphasized that patients should receive a detailed medical evaluation before using fruquintinib and fully communicate with their doctor to understand the potential risks and benefits of the drug. Patients should only use fruquintinib if their doctor clearly believes it is a safe and appropriate treatment option. In addition, patients should receive regular monitoring and follow-up from their doctor during medication to ensure safe and effective treatment.

Fruquintinib is a drug developed in Hong Kong, China. It has been approved for marketing by the State Food and Drug Administration and has been included in medical insurance. Patients can buy it in domestic hospital pharmacies at a price of about one to two thousand. For specific prices, please consult the local hospital pharmacy.